-
1 Comment
COSMOS Pharmaceutical Corporation is currently in a long term downtrend where the price is trading 4.1% below its 200 day moving average.
From a valuation standpoint, the stock is 98.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.9.
COSMOS Pharmaceutical Corporation's total revenue rose by 8.9% to $175B since the same quarter in the previous year.
Its net income has increased by 50.0% to $6B since the same quarter in the previous year.
Based on the above factors, COSMOS Pharmaceutical Corporation gets an overall score of 3/5.
| Sector | Healthcare |
|---|---|
| Industry | Pharmaceutical Retailers |
| Exchange | TSE |
| CurrencyCode | JPY |
| ISIN | JP3298400007 |
| Market Cap | 706B |
|---|---|
| PE Ratio | 23.99 |
| Beta | 0.28 |
| Target Price | 8870 |
| Dividend Yield | 0.7% |
COSMOS Pharmaceutical Corporation engages in the retail sale of pharmaceuticals, cosmetics, daily necessities, food, etc. in Japan. It also sells its products through online stores. The company was incorporated in 1983 and is headquartered in Fukuoka City, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 3349.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
